It’s true: we do enjoy kicking MedMen (MMEN.C) around. Why do we dislike this grotesquely unprofitable company so intensely? Because Adam Bierman (CEO) and Andrew Modlin (President) are greedy….
MedMen
Cannara Biotech (LOVE.C) is a pig. I mean, okay. Pigs are actually kind of cool, they’re smart and bacon tastes good and they like a tummy rub, so Cannara is…
This week, MedMen (MMEN.C) attempted to shine a light on a wall to distract folks from their ongoing lawsuits and revelations of free spending, bonus-enriched execs, by revealing a…
People sometimes ask me for advice. The two questions I’m asked most are, ‘What stock is going up next’ and ‘Why should I listen to you?’ The answer to…
On January 29, 2019 MedMen’s (MMEN.C) fired CFO, James Parker launched a 55-page lawsuit, viewable in PDF form on the excellent website of mjbizdaily. Here is the “Coles’ Notes”…
The technique is as old as the wind. When a company has bad news, it waits until the stock markets have closed on Friday – then publishes the news…
On November 29, 2018 at 5 p.m. eastern time, cannabis retailer MedMen (MMEN.C) released a 65-page consolidated financial report, followed by a 63-page management discussion of its Q1, 2019…
First, on behalf of Equity.Guru: Legalization day was a fire sale. Some provinces sold more than others. Alberta made $730,000 worth of sales on their first day. Nunavut’s sales…
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has…
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682…